CYTK - CYTOKINETICS INC

QQQ $ 625.25 $ 0.00 (0 %)

DIA $ 480.62 $ 0.00 (0 %)

SPY $ 685.28 $ 0.00 (0 %)

TLT $ 89.78 $ 0.00 (0 %)

GLD $ 380.00 $ 0.00 (0 %)

Previous Close

$ 66.5

Open

$ 62.16

Bid

$ 66.73 x 23

Ask

$ 69.00 x 50

Day's Range

-- - --

52 Week Range

$ 29.31 - $ 66.72

Volume

2,417,610

Average Volume

Market Cap

8.13B

Beta (5Y Monthly)

$ 0.95

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-05-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-06-2025	03-31-2025	10-Q
4	02-27-2025	01-01-1970	10-K
5	11-07-2024	09-30-2024	10-Q
6	08-09-2024	06-30-2024	10-Q
7	05-10-2024	03-31-2024	10-Q
8	02-28-2024	12-31-2023	10-K
9	11-03-2023	09-30-2023	10-Q
10	08-03-2023	06-30-2023	10-Q
11	05-05-2023	03-31-2023	10-Q
12	03-01-2023	12-31-2022	10-K
13	11-04-2022	09-30-2022	10-Q
14	08-05-2022	06-30-2022	10-Q
15	05-06-2022	03-31-2022	10-Q
16	02-25-2022	12-31-2021	10-K
17	11-05-2021	09-30-2021	10-Q
18	08-06-2021	06-30-2021	10-Q
19	05-07-2021	03-31-2021	10-Q
20	02-26-2021	12-31-2020	10-K
21	11-06-2020	09-30-2020	10-Q
22	08-10-2020	06-30-2020	10-Q
23	05-08-2020	03-31-2020	10-Q
24	03-04-2020	12-31-2019	10-K
25	11-01-2019	09-30-2019	10-Q
26	08-09-2019	06-30-2019	10-Q
27	05-09-2019	03-31-2019	10-Q
28	03-07-2019	12-31-2018	10-K
29	11-09-2018	09-30-2018	10-Q
30	08-07-2018	06-30-2018	10-Q
31	05-10-2018	03-31-2018	10-Q
32	03-05-2018	12-31-2017	10-K
33	11-03-2017	09-30-2017	10-Q
34	08-04-2017	06-30-2017	10-Q
35	05-04-2017	03-31-2017	10-Q
36	03-06-2017	12-31-2016	10-K
37	11-03-2016	09-30-2016	10-Q
38	08-04-2016	06-30-2016	10-Q
39	05-05-2016	03-31-2016	10-Q
40	03-03-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

RBC Capital Maintains Outperform on Cytoki...
11/11/2025 15:21:37

RBC Capital analyst Leonid Timashev maintains Cytokinetics (NASDAQ:CYTK) with a Outperform and raises the price target from ...

B. Riley Securities Reiterates Buy on Cyto...
11/10/2025 14:51:15

B. Riley Securities analyst Mayank Mamtani reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and raises the price target from...

Cytokinetics Presents Additional Data From...
11/10/2025 12:44:35

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that additional data from MAPLE-HCM (Metoprolol vs Aficamten in Patie...

CORRECTION: Cytokinetics Q3 Adj. EPS $(1.5...
11/05/2025 23:44:18

Cytokinetics (NASDAQ:CYTK) reported quarterly losses of $(1.54) per share which beat the analyst consensus estimate of $(1.58) ...

Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

Barclays Maintains Overweight on Cytokinet...
10/06/2025 13:00:38

Barclays analyst Gena Wang maintains Cytokinetics (NASDAQ:CYTK) with a Overweight and raises the price target from $71 to $82.

B of A Securities Maintains Neutral on Cyt...
10/02/2025 18:15:52

B of A Securities analyst Jason Zemansky maintains Cytokinetics (NASDAQ:CYTK) with a Neutral and raises the price target fro...

cal-maine-foods-posts-downbeat-earnings-joins-enanta-pharmaceuticals-aar-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session

Cal-Maine Foods Posts Downbeat Earnings, J...
10/01/2025 12:16:06

HC Wainwright & Co. Reiterates Buy on Cyto...
09/29/2025 16:19:15

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ: CYTK) with a Buy and maintains $120 price ...

Cytokinetics Presents Additional Data Rela...
09/29/2025 11:36:16

Additional Data from MAPLE-HCM Show Aficamten Significantly Improves Measures of Maximaland Submaximal Exercise Capacity and Re...

B. Riley Securities Maintains Buy on Cytok...
09/22/2025 15:34:44

B. Riley Securities analyst Mayank Mamtani maintains Cytokinetics (NASDAQ:CYTK) with a Buy and raises the price target from ...

HC Wainwright & Co. Reiterates Buy on Cyto...
09/22/2025 10:39:35

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cytokinetics (NASDAQ:CYTK) with a Buy and maintains $120 price t...

Reported Earlier, Cytokinetics Prices Upsi...
09/17/2025 06:43:23

On Sept 15, Cytokinetics Participates In F...
09/16/2025 20:15:34

-SEC Filing

Cytokinetics Announces $550M Private Offer...
09/16/2025 20:03:20

Cytokinetics, Incorporated ("Cytokinetics") (NASDAQ:CYTK) today announced its intention to offer, subject to market con...

Barclays Maintains Overweight on Cytokinet...
09/03/2025 14:17:29

Barclays analyst Gena Wang maintains Cytokinetics (NASDAQ:CYTK) with a Overweight and raises the price target from $53 to $71.

Evercore ISI Group Maintains Outperform on...
09/03/2025 13:38:42

Evercore ISI Group analyst Cory Kasimov maintains Cytokinetics (NASDAQ:CYTK) with a Outperform and raises the price target f...

10 Health Care Stocks Whale Activity In To...
09/02/2025 17:35:29

12 Health Care Stocks Moving In Tuesday's ...
09/02/2025 17:06:49

dow-tumbles-over-1-nio-shares-edge-lower-after-q2-results

Dow Tumbles Over 1%; Nio Shares Edge Lower...
09/02/2025 16:55:35